0000000001289030

AUTHOR

Nd Cascio

Basse Dosi di Ketamina nella Modulazione dell’Iperalgesia Post-Operatoria da Remifentanil in Chirurgia Addominale Maggiore

research product

Fibrinolysis Sistem, Monitored by Thromboelastography (TEG), and PAI-1 Activity in Septic Patients Undergoing Tight Glycemic Control

research product

Intracranial Venous Thrombosis in Peripartum: Case Report.

research product

Fondaparinux vs Low Molecular Weight Heparin as a Thromboprophylaxis in Critically Ill Patients. Coagulation Status Monitored by Thromboelastography (TEG)

research product

LyghtCycler Septifast in early diagnosis of sepsis: our experience.

research product

Concentrazione Citochimica e Markers Coagulativi nel BAL e nel Siero di Pazienti con ALI Settici vs non-Settici

research product

Embolia Polmonare in un Paziente con Shock Settico da Infarto Intestinale. rhaPC+LMWH o NFH+ATIII? Case Report

research product

Profilassi Antitrombotica con Fondaparinux vs Eparina a Basso Peso Molecolare. Monitoraggio Mediante Tromboelastogramma (TEG).

research product

LightCycler SeptiFast in early diagnosis of sepsis: our experience.

The conventional sepsis diagnosis, using the cultivation technique, needs 24 hours for bacterial identification and 36 hours for fungal. The use of empiric therapy makes the growth of bacteria and fungi slower or may yield negative findings in many cases of septic shock. The molecular technique can contribute to a more rapid and specific diagnosis in septic patients. SeptiFast detects 26 bacterial and fungal species DNAs, using the PCR in real time and giving results after 6 hours. This is important for de-escalation therapy and beginning of appropriate antibiotic treatment. The aim of this study is to evaluate the sensibility and the specificity of the SeptiFast test versus traditional dia…

research product

LightCycler Septifast® and VCS: Relationship Between Two Innovative Instruments in Severe Sepsis and Septic Shock

research product